U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H29N5O3
Molecular Weight 483.5616
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LECOZOTAN

SMILES

C[C@H](CN(C(=O)C1=CC=C(C=C1)C#N)C2=CC=CC=N2)N3CCN(CC3)C4=C5OCCOC5=CC=C4

InChI

InChIKey=NRPQELCNMADTOZ-OAQYLSRUSA-N
InChI=1S/C28H29N5O3/c1-21(31-13-15-32(16-14-31)24-5-4-6-25-27(24)36-18-17-35-25)20-33(26-7-2-3-12-30-26)28(34)23-10-8-22(19-29)9-11-23/h2-12,21H,13-18,20H2,1H3/t21-/m1/s1

HIDE SMILES / InChI

Molecular Formula C28H29N5O3
Molecular Weight 483.5616
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

LECOZOTAN, a benzodioxanylpiperazine derivative, is a selective serotonin 1A receptor antagonist. It was in development for the symptomatic treatment of cognitive deficits in Alzheimer's disease.

Approval Year

PubMed

PubMed

TitleDatePubMed
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
2005 May 19
Drug development for Alzheimer's disease: recent progress.
2010 Dec
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:39:10 UTC 2023
Edited
by admin
on Fri Dec 15 15:39:10 UTC 2023
Record UNII
48854OTZ5E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LECOZOTAN
INN  
INN  
Official Name English
4-CYANO-N-((2R)-2-(4-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)PIPERAZIN-1-YL)PROPYL)-N-(PYRIDIN-2-YL)BENZAMIDE
Systematic Name English
BENZAMIDE, 4-CYANO-N-((2R)-2-(4-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)-1-PIPERAZINYL)PROPYL)-N-2-PYRIDINYL-
Systematic Name English
lecozotan [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C66885
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
Code System Code Type Description
PUBCHEM
10116877
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
SMS_ID
100000126191
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
FDA UNII
48854OTZ5E
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
CAS
434283-16-6
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
MESH
C500836
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
WIKIPEDIA
LECOZOTAN
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
ChEMBL
CHEMBL372205
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
EVMPD
SUB33289
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
INN
8489
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
EPA CompTox
DTXSID30870354
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
NCI_THESAURUS
C74394
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
DRUG BANK
DB12540
Created by admin on Fri Dec 15 15:39:10 UTC 2023 , Edited by admin on Fri Dec 15 15:39:10 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY